ASEAN Point of Care Diagnostics Market worth $1.36 billion by 2030
The report "ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030"ASEAN point of care diagnostics market is valued at an estimated USD 1.08 billion in 2025 and is projected to reach USD 1.36 billion by 2030, at a CAGR of 4.7% during the forecast period.
Browse 268 market data Tables and 51 Figures spread through 333 Pages and in-depth TOC on "ASEAN Point of Care Diagnostics Market by Product (Infectious Disease (TB, Hepatitis, STDs, HAIs), Glucose, Cardiometabolic, Pregnancy, Coagulation), Technology (Lateral Flow Assays, Biochemistry, MDx), End User (Home Care, Hospitals) - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asean-north-asian-point-care-rapid-diagnostics-market-219733165.html
The ASEAN point of care diagnostics market is expanding substantially, led primarily by the increasing incidence of chronic & infectious diseases. The growing burden of these diseases has fueled the demand for rapid, convenient diagnostic solutions that facilitate early detection, timely monitoring, and efficient disease management. In addition, favorable government policies for the growth of point of care testing and the development of public-private partnerships to build healthcare infrastructure are also expected to drive market growth. Additionally, growing government spending on screening programs and the continued decentralization of healthcare services that enhance access to diagnostic tests in urban & rural areas are driving the demand for point of care diagnostics. Overall, efforts towards improving the accessibility of early diagnosis, streamlining healthcare spending, and advancing patient care are expected to stimulate the demand for POC diagnostic solutions across the ASEAN region.
In 2024, the glucose monitoring products segment accounted for the largest market share of the ASEAN point of care diagnostics market, by product.
Based on product, the ASEAN point of care diagnostics market is segmented into infectious disease testing products, glucose monitoring products, cardiometabolic testing products, coagulation monitoring products, pregnancy & fertility testing products, urinalysis testing products, cancer marker testing products, cholesterol testing products, hematology testing products, fecal occult testing products, drugs-of-abuse testing products, and other POC products.
Among these, the glucose monitoring products segment accounted for the largest share of the market. The key factors contributing to market growth include the increasing prevalence of diabetes and the growing demand for accurate and rapid glucose testing devices. Recent technological advancements in this market have also fueled the demand for compact, affordable devices, which is expected to contribute to market growth among patients and healthcare professionals across the ASEAN market.
In 2024, the home care settings segment accounted for the largest share of the ASEAN point of care diagnostics market, by end user.
The ASEAN point of care diagnostics market is segmented by end users into clinical laboratories, hospitals and critical care centers, outpatient settings and ambulatory care centers, home care settings, and other end users. The home care settings segment accounted for the largest market share in 2024. The rising demand for convenience and patient comfort fuels the trend toward home-based testing solutions, enabling individuals to track their health from home without frequent trips to healthcare centers. The convenience of accessing rapid results, especially for managing chronic diseases like diabetes, has further supported the use of home testing devices. Moreover, technological advances have enhanced the accuracy, user-friendliness, and affordability of home-based diagnostic devices so patients can conduct tests with minimal training. With the rising incidence of chronic diseases throughout the ASEAN region and growing interest in preventive care and self-management, the home care settings segment is expected to witness significant growth in the ASEAN point of care diagnostics market.
In 2024, Indonesia accounted for the largest share of the ASEAN point of care diagnostics market.
The ASEAN point of care diagnostics market has been segmented into ten countries: Vietnam, Laos, Cambodia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Indonesia, and Brunei. Indonesia was the largest market in the ASEAN region in 2024, driven by its large population and increasing healthcare requirements. The rising incidence of infectious & chronic diseases has fueled the demand for quick, accurate, and affordable diagnostic products, particularly in home & decentralized environments. Government programs such as the Jaminan Kesehatan Nasional (JKN) program have promoted healthcare coverage, facilitating early diagnosis and preventative treatment. Improved healthcare investments, public-private alliances, and health awareness also necessitate POC diagnostics throughout the country.
The leading players operating in the market are Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan), Danaher Corporation (US), BD (US), QuidelOrtho Corporation (US), Cardinal Health (US), AccuBioTech Co., Ltd. (China), EKF Diagnostics Holdings plc (UK), bioMérieux (France), Thermo Fisher Scientific Inc. (US), BIOSYNEX SA (France), PTS Diagnostics (US), LifeScan IP Holdings, LLC (US), SD Biosensor, INC. (South Korea), CTK Biotech, Inc. (US), Wondfo (China), Trinity Biotech (Ireland), SEKISUI Diagnostics (US), Werfen (Spain), ARKRAY, Inc. (US), Xiamen Boson Biotech Co., Ltd. (China), Credo Diagnostics Biomedical Pte. Ltd. (Singapore), Anbio Biotechnology Inc. (Germany), and SG Diagnostics (Singapore).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the ASEAN Point of Care Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
